Efficient Repression of Endogenous Major Histocompatibility Complex Class II Expression through Dominant Negative CIITA Mutants Isolated by a Functional Selection Strategy
Open Access
- 1 August 1997
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 17 (8) , 4249-4258
- https://doi.org/10.1128/mcb.17.8.4249
Abstract
Major histocompatibility complex class II (MHC-II) molecules present peptide antigens to CD4-positive T cells and are of critical importance for the immune response. The MHC-II transactivator CIITA is essential for all aspects of MHC-II gene expression examined so far and thus constitutes a master regulator of MHC-II expression. In this study, we generated and analyzed mutant CIITA molecules which are able to suppress endogenous MHC-II expression in a dominant negative manner for both constitutive and inducible MHC-II expression. Dominant negative CIITA mutants were generated via specific restriction sites and by functional selection from a library of random N-terminal CIITA deletions. This functional selection strategy was very effective, leading to strong dominant negative CIITA mutants in which the N-terminal acidic and proline/serine/threonine-rich regions were completely deleted. Dominant negative activity is dependent on an intact C terminus. Efficient repression of endogenous MHC-II mRNA levels was quantified by RNase protection analysis. The quantitative effects of various dominant negative CIITA mutants on mRNA expression levels of the different MHC-II isotypes are very similar. The optimized dominant negative CIITA mutants isolated by functional selection should be useful for in vivo repression of MHC-II expression.Keywords
This publication has 45 references indexed in Scilit:
- REGULATION OF MHC CLASS II GENES: Lessons from a DiseaseAnnual Review of Immunology, 1996
- Tissue-specific inactivation of p53 tumor suppression in the mouse.Genes & Development, 1996
- Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genesImmunology Today, 1995
- Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITAScience, 1994
- Following a diabetogenic T cell from genesis through pathogenesisCell, 1993
- Sequences and Factors: A Guide to MHC Class-II TranscriptionAnnual Review of Immunology, 1992
- Transformation suppressor activity of a Jun transcription factor lacking its activation domainNature, 1991
- Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-XCell, 1988
- A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressorCell, 1985
- Quantitative variation in la antigen expression plays a central role in immune regulationImmunology Today, 1984